Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients
Rapid Bacterial Identification and Antibiotic Resistance Testing in Critically Ill Adults at Risk for Ventilator Acquired Pneumonia (VAP).
Sponsor: Accerl8 Technology Corporation
A observational or N/A phase clinical study on Ventilator Acquired Pneumonia, this trial is completed. The trial is conducted by Accerl8 Technology Corporation and has accumulated 12 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Oct 2018 — Jan 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Accerl8 Technology Corporation
- Denver Health and Hospital Authority
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .